Sino Biological recombinant allergen proteins are core reagents for allergen detection

« Previous article
ATCC Reporter-Labele...

2nd September 2014  Content supplied by: Clinical and Laboratory Standards Institute

New CLSI Standard for Detection of Anaerobes in Clinical Labs

The Clinical and Laboratory Standards Institute (CLSI) have released a new microbiology standard, Principles and Procedures for Detection of Anaerobes in Clinical Specimens; Approved Guideline (M56-A). This document presents standardized, cost-effective, and efficient best practice processes for anaerobe bacteriology to assist clinical laboratories in selecting those methods that lead to improved patient care.

“M56-A is an up-to-date manual for anaerobic bacteriology written to guide the novice microbiologist as well as those experienced with anaerobes,” notes Document Development Committee Chairholder, Maria D. Appleman, PhD, Professor of Clinical Pathology at the University of Southern California in Los Angeles, California, USA. “The document can be used as an introduction to anaerobes and their role in the human disease, as guidance for clinical laboratories in specimen processing and media selection with both easy and complex techniques for culture and isolate identifications, or as a learning tool for the new nomenclature used in the field.

M56-A provides guidance for preexamination, examination, and postexamination procedures associated with the culture of anaerobic bacteria. It includes methods for collecting proper specimens from appropriate clinical sites and for transport procedures that protect anaerobes from oxygen exposure so all pathogens involved in infections can be detected. The document contains color photographs of Gram stain reactions and colonial morphology, easy-to-follow identification tables, and in-depth explanations of new technology, and it discusses the clinical significance of taxonomic names.

The document contains recommendations for interpreting results, assistance in understanding the value of rapid preliminary results, and guidance on issues of quality control, quality assurance, and competency. M56-A is intended for use by medical technologists, infectious disease physicians, microbiology laboratory directors, pathologists, and researchers.



Date Published: 2nd September 2014

Source article link: View

View full company details